Jung Eun Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jung Eun Park has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Ki Sung Kang
College of Korean Medicine, Gachon University, Seongnam 13120, Republic of Korea
2 shared publications - Bum-Jin Park
Department of Environment and Forest Resources, Chungnam National University, Daejeon, Korea
1 shared publication - Chan Hee Cho
School of Pharmacy, Sungkyunkwan University, Suwon, Korea
1 shared publication Changjin Lim
School of Pharmacy, Jeonbuk National University, Jeonju, Korea
1 shared publication- Daesik Jeong
College of Convergence Engineering, Sangmyung University, Seoul, Republic of Korea
1 shared publication Hyun Joo Shim
School of Pharmacy, Jeonbuk National University, Jeonju, Korea
1 shared publication
Latest Publications
- Open Access
- 30 September 2026
- Published by Drug Targets and Therapeutics (DTT) - Pharmaceutical Society of Korea in Drug Targets and Therapeutics
- Vol. 5 (2) , 99-108
Chemical Constituents from Suaeda glauca and Their Protective Effects against Dexamethasone-Induced Muscle Atrophy in C2C12 Myotubes
Chan Hee Cho, Jung Eun Park, Jong-Sik Jin, Changjin Lim, Hyun Joo Shim, Ki Sung Kang, Ki Hyun Kim. DTT 2026;5:99-108. https://doi.org/10.58502/DTT.26.0016
- 30 September 2026
- Published by Drug Targets and Therapeutics (DTT) - Pharmaceutical Society of Korea in Drug Targets and Therapeutics
- Vol. 5 (2) , 99-108
Open AccessChemical Constituents from Suaeda glauca and Their Protective Effects against Dexamethasone-Induced Muscle Atrophy in C2C12 Myotubes
Chan Hee Cho, Jung Eun Park, Jong-Sik Jin, Changjin Lim, Hyun Joo Shim, Ki Sung Kang, Ki Hyun Kim. DTT 2026;5:99-108. https://doi.org/10.58502/DTT.26.0016
- Open Access
- 30 June 2026
- Published by Jaseng Medical Foundation in Perspectives on Integrative Medicine
- Vol. 5 (2) , 118-129
A Systematic Antidiabetic Screening Approach Integrating In Vitro Assays and In Silico Analysis: Evaluation of Glucose-Regulatory Activity and Prediction of Bioactive Components in Plant Derived Materials
Background: Type 2 diabetes mellitus involves multifactorial metabolic dysfunction necessitating therapeutic strategies capable of modulating multiple biological pathways.Methods: This study implemented a 4-stage integrated screening platform to identify natural products with multitarget antidiabetic potential.Results: Five plant samples samples were evaluated through α-glucosidase inhibition, protein tyrosine phosphatase 1B inhibition, glucoseuptake enhancement assays in C2C12 myotubes, and network pharmacology. Amongst them, Lagerstroemia speciosa (banaba leaf) was the only material that demonstrated coherent activity across all assays. Banaba extract significantly inhibited α-glucosidase, enhanced glucose uptake in a dose-dependent manner, and exhibited measurable protein tyrosine phosphatase suppression. Network pharmacology further supported these findings and 13 overlapping targets and 19 hub genes enriched in insulin signaling pathways (PI3K-Akt, AMPK, MAPK, and FOXO) were identified. This reflected strong mechanistic relevance of banaba leaf to Type 2 diabetes mellitus.Conclusion: Collectively, these results demonstrate the utility of a systematic, multilevel screening framework which highlights banaba leaf as a promising candidate for further antidiabetic research. Nevertheless, reliance on in vitro and in silico analyses underscores the need for in vivo validation to determine physiological efficacy, bioavailability, and systemic metabolic effects.
- 30 June 2026
- Published by Jaseng Medical Foundation in Perspectives on Integrative Medicine
- Vol. 5 (2) , 118-129
Open AccessA Systematic Antidiabetic Screening Approach Integrating In Vitro Assays and In Silico Analysis: Evaluation of Glucose-Regulatory Activity and Prediction of Bioactive Components in Plant Derived Materials
Background: Type 2 diabetes mellitus involves multifactorial metabolic dysfunction necessitating therapeutic strategies capable of modulating multiple biological pathways.Methods: This study implemented a 4-stage integrated screening platform to identify natural products with multitarget antidiabetic potential.Results: Five plant samples samples were evaluated through α-glucosidase inhibition, protein tyrosine phosphatase 1B inhibition, glucoseuptake enhancement assays in C2C12 myotubes, and network pharmacology. Amongst them, Lagerstroemia speciosa (banaba leaf) was the only material that demonstrated coherent activity across all assays. Banaba extract significantly inhibited α-glucosidase, enhanced glucose uptake in a dose-dependent manner, and exhibited measurable protein tyrosine phosphatase suppression. Network pharmacology further supported these findings and 13 overlapping targets and 19 hub genes enriched in insulin signaling pathways (PI3K-Akt, AMPK, MAPK, and FOXO) were identified. This reflected strong mechanistic relevance of banaba leaf to Type 2 diabetes mellitus.Conclusion: Collectively, these results demonstrate the utility of a systematic, multilevel screening framework which highlights banaba leaf as a promising candidate for further antidiabetic research. Nevertheless, reliance on in vitro and in silico analyses underscores the need for in vivo validation to determine physiological efficacy, bioavailability, and systemic metabolic effects.